Lv Xianli, Zhang Yupeng, Jiang Weijian
Department of Neurosurgery, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, China; New Era Stroke Care and Research Institute, The PLA Rocket Force General Hospital, Beijing, China.
Beijing Neurosurgical Institute and Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
World Neurosurg. 2018 Feb;110:20-25. doi: 10.1016/j.wneu.2017.10.113. Epub 2017 Oct 28.
Although the Woven EndoBridge (WEB [Sequent Medical, Aliso Viejo, California, USA]) is a highly innovative technique for the endovascular treatment of wide-necked bifurcation aneurysms (WNBAs), there are no studies available comparing this technique with surgical results or other endovascular results of stent-assisted coiling or balloon-assisted coiling for WNBAs. The purpose of this study was to assess complications, complete occlusion rate, and morbidity and mortality of the WEB in WNBA treatment.
Published literature citing embolization results for WNBAs using the WEB was reviewed. A systematic review was performed to evaluate the complications, complete occlusion rate, and morbidity and mortality.
We identified 19 studies, including 935 patients. The most frequent aneurysm locations were the bifurcation of the middle cerebral artery (MCA) (42.8%), the anterior communicating artery (23%), and the basilar bifurcation (20.8%). The technical success rate of the WEB was 97% (95% confidence interval [CI], 96%-98%). The thromboembolic complication rate was 8% (95% CI, 6%-11%). The thromboembolic complication rate was 10% (95% CI, 7%-13%) in cases before 2013, which was higher than in cases after 2013 (6%; 95% CI, 4%-9%; P = 0.045). MCA bifurcation aneurysm has a higher thromboembolic complication rate than posterior circulation aneurysm. The overall bleeding complication rate of the WEB was 2% (95% CI, 1%-3%). The adequate occlusion rate was 81% (95% CI, 76%-85%). Morbidity during follow-up was 3% (95% CI, 1%-4%) (I = 30.4%), and mortality was 2% (95% CI, 1%-3%).
Adequate aneurysm occlusion was found in 81% of WEB cases with low morbidity and mortality.
尽管编织型血管内桥接装置(WEB [美国加利福尼亚州阿利索维耶荷市的Sequent Medical公司生产])是一种用于血管内治疗宽颈分叉动脉瘤(WNBA)的极具创新性的技术,但尚无研究将该技术与手术治疗结果或其他血管内支架辅助弹簧圈栓塞或球囊辅助弹簧圈栓塞治疗WNBA的结果进行比较。本研究的目的是评估WEB治疗WNBA的并发症、完全闭塞率以及发病率和死亡率。
回顾已发表的引用使用WEB栓塞WNBA结果的文献。进行系统评价以评估并发症、完全闭塞率以及发病率和死亡率。
我们纳入了19项研究,共935例患者。最常见的动脉瘤部位是大脑中动脉(MCA)分叉处(42.8%)、前交通动脉(23%)和基底动脉分叉处(20.8%)。WEB的技术成功率为97%(95%置信区间[CI],96% - 98%)。血栓栓塞并发症发生率为8%(95% CI,6% - 11%)。2013年之前的病例中血栓栓塞并发症发生率为10%(95% CI,7% - 13%),高于2013年之后的病例(6%;95% CI,4% - 9%;P = 0.045)。MCA分叉处动脉瘤的血栓栓塞并发症发生率高于后循环动脉瘤。WEB的总体出血并发症发生率为2%(95% CI,1% - 3%)。充分闭塞率为81%(95% CI,76% - 85%)。随访期间的发病率为3%(95% CI,1% - 4%)(I = 30.4%),死亡率为2%(95% CI,1% - 3%)。
在81%的WEB病例中发现动脉瘤充分闭塞,且发病率和死亡率较低。